The company attributes its success to double-digit growth in international markets, such as Asia Pacific and Latin America. A further driving factor in the growing sales was new product launches in the European markets.
Consolidated net sales in the North American market were $567.3 million, approximately 5 percent higher than the third quarter last year. European net sales were reported as $230.6 million, a 17.3 percent growth. The Asian Pacific market experienced nearly 30 percent growth to $74.8 million.
The company reported satisfactory spine sales despite declining procedure volumes and reimbursement pressures from the United States. The company is currently in the middle of finalizing an acquisition by Johnson & Johnson.
Related Articles on Orthopedic Devices:
More Insurance Companies Now Reimburse for TranS1’s AxiaLIF
Zimmer Signs Distribution Agreement for Benvenue Medical’s Vertebral Compression Fracture Treatment System
Stryker’s Net Earnings Decline, Acquisitions Save Sales Growth
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.